Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents

Journal of Infectious Diseases

Volumn 173, Issue 4, 1996, Pages 909-913

  Brandt, Claudia M ^b   Rouse, Mark S ^b   Laue, Natasha W ^b   Stratton, Charles W ^b   Wilson, Walter R ^b   Steckelberg, James M ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; IMIPENEM; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; INTRAVENOUS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029948028     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.4.909     Document Type: Article

References (8)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med 1991;91(suppl 3B):72-5.
2. Moellering RC Jr. The enterococci: an enigma and a continuing therapeutic challenge. Eur J Clin Microbiol Infect Dis 1990;9:73-4.
3. Eliopoulos GM. Aminoglycoside-resistant enterococcal endocarditis. Infect Dis Clin North Am 1993;7:117-33.
4. Nachamkin I, Axelrod P, Talbot GH, et al. Multiply high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital. J Clin Microbiol 1988;26:1287-91.
5. Weems JJ, Lowrance JH, Baddour LM, Simpson WA. Molecular epidemiology of nosocomial, multiply aminoglycoside resistant Enterococcus faecalis. J Antimicrob Chemother 1989;24:121-30.
6. Hellinger WC, Rouse MS, Rabadan PM, Henry NK, Steckelberg JM, Wilson WR. Continuous intravenous versus intermittent ampicillin ther-apy of experimental endocarditis caused by aminoglycoside-resistant enterococci. Antimicrob Agents Chemother 1992;36:1272-5.
7. Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC Jr. Contributions of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin. Clin Infect Dis 1992;15:58-62.
8. Thauvin C, Eliopoulos GM, Willey S, Wennersten C, Moellering RC Jr. Continuous infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother 1987;31:139-43.